Medicaldevicehub

NCT ID:	NCT04669626
NLM Download Date Description:	N/A
Study First Submitted Date:	2020-12-09
Last Update Submitted Date:	2021-09-21
Last Update Submitted Date:	2021-09-21
Result First Submitted Date:	N/A
Disposition First Submitted Date:	N/A
Start Month Year:	July 1, 2020
Start Date:	2020-07-01
Start Date Type:	Actual
Verification Month Year:	September 2021
Verification Date:	2021-09-30
Completion Month Year:	December 31, 2021
Completion Date:	2021-12-31
Completion Date Type:	Anticipated
Primary Completion Month Year:	November 30, 2021
Primary Completion Date:	2021-11-30
Primary Completion Date Type:	Anticipated
Study first Submitted QC Date:	2020-12-09
Study first posted Date:	2020-12-17
Result first Submitted QC Date:	N/A
Result First Posted Date:	N/A
Disposition First Submitted QC Date:	N/A
Disposition First Posted Date:	N/A
Last Updated Submitted QC Date:	2021-09-21
Last Updated Posted Date:	2021-09-22
Target Duration:	N/A
Study Type:	Interventional
Acronym:	Odour
Baseline Population:	N/A
Brief Title:	The Ability of Octenilin® to Reduce Odour of Malodorous Wound
Official Title:	The Ability of Octenilin® to Reduce Odour of Malodorous Wound - a Single-center Randomized Double Blinded Controlled Pilot Study
Overall Status:	Recruiting
Last Known Status:	N/A
Phase:	Not Applicable
Enrollment:	20
Enrollment Type:	Anticipated
Source:	School of Health Sciences Geneva
Limitation and Caveats:	N/A
Number of Arms:	2
Number of Groups:	N/A
Why Stopped:	N/A
Has Expanded Access:	N/A
Expanded Access Type Individual:	N/A
Expanded Access Type Intermediate:	N/A
Expanded Access Type Treatment:	N/A
Has DMC:	true
Is it FDA Regulated Drug:	N/A
Is it FDA Regulated Device:	N/A
Is it Unapproved Device:	N/A
Is PPSD:	N/A
Is US Export:	N/A
Is Biospec Retention:	N/A
Biospec Description:	N/A
Plan to Share IPD:	No
Plan to Share IPD Description:	data will be ananymised
IPD Time Frame:	N/A
IPD Access Criteria:	N/A
IPD URL:	N/A

NCT ID:

NCT04669626

NLM Download Date Description:

N/A

Study First Submitted Date:

2020-12-09

Last Update Submitted Date:

2021-09-21

Last Update Submitted Date:

2021-09-21

Result First Submitted Date:

N/A

Disposition First Submitted Date:

N/A

Start Month Year:

July 1, 2020

Start Date:

2020-07-01

Start Date Type:

Actual

Verification Month Year:

September 2021

Verification Date:

2021-09-30

Completion Month Year:

December 31, 2021

Completion Date:

2021-12-31

Completion Date Type:

Anticipated

Primary Completion Month Year:

November 30, 2021

Primary Completion Date:

2021-11-30

Primary Completion Date Type:

Anticipated

Study first Submitted QC Date:

2020-12-09

Study first posted Date:

2020-12-17

Result first Submitted QC Date:

N/A

Result First Posted Date:

N/A

Disposition First Submitted QC Date:

N/A

Disposition First Posted Date:

N/A

Last Updated Submitted QC Date:

2021-09-21

Last Updated Posted Date:

2021-09-22

Target Duration:

N/A

Study Type:

Interventional

Acronym:

Odour

Baseline Population:

N/A

Brief Title:

The Ability of Octenilin® to Reduce Odour of Malodorous Wound

Official Title:

The Ability of Octenilin® to Reduce Odour of Malodorous Wound - a Single-center Randomized Double Blinded Controlled Pilot Study

Overall Status:

Recruiting

Last Known Status:

N/A

Phase:

Not Applicable

Enrollment:

20

Enrollment Type:

Anticipated

Source:

School of Health Sciences Geneva

Limitation and Caveats:

N/A

Number of Arms:

2

Number of Groups:

N/A

Why Stopped:

N/A

Has Expanded Access:

N/A

Expanded Access Type Individual:

N/A

Expanded Access Type Intermediate:

N/A

Expanded Access Type Treatment:

N/A

Has DMC:

true

Is it FDA Regulated Drug:

N/A

Is it FDA Regulated Device:

N/A

Is it Unapproved Device:

N/A

Is PPSD:

N/A

Is US Export:

N/A

Is Biospec Retention:

N/A

Biospec Description:

N/A

Plan to Share IPD:

No

Plan to Share IPD Description:

data will be ananymised

IPD Time Frame:

N/A

IPD Access Criteria:

N/A

IPD URL:

N/A

Detailed Result for NCT04669626